Brand:
Dragon Pharma, Europe
Manufacturer:
Dragon Pharma, Europe
Dosage Info:
<div class="tab-pane fade" id="offer-tabbody--dosage-and-usage" role="tabpanel">
<section class="tab-panel" id="panel-usage">
<h2>Dosage & Usage Guidelines</h2>
<p>Selank is typically administered via subcutaneous injection or intranasally. General dosing protocols include:</p>
<ul>
<li><strong>Initial phase:</strong> 250 mcg per day</li>
<li><strong>Week 3-4:</strong> 500 mcg per day</li>
<li><strong>Maintenance:</strong> 250–500 mcg every 2–3 days as needed</li>
</ul>
<p>It pairs well with other nootropic agents or peptides like Semaglutide that contribute to mental and metabolic health. Dosing should be tailored under medical supervision.</p>
<h3>Potential Benefits</h3>
<ul>
<li>Reduced anxiety and improved emotional resilience</li>
<li>Enhanced memory formation and concentration</li>
<li>Improved sleep quality and circadian rhythm</li>
<li>Neuroprotection against stress-induced damage</li>
</ul>
<h3>Possible Side Effects</h3>
<p>Selank is generally well-tolerated with minimal side effects. Some users may experience:</p>
<ul>
<li>Mild nasal or injection site irritation</li>
<li>Drowsiness (rare and dose-dependent)</li>
<li>Headaches or fatigue at high doses</li>
</ul>
<p>These symptoms are usually mild and temporary. Always begin with a conservative dose to assess tolerance.</p>
<h3>Example Selank Cycle</h3>
<ul>
<li><strong>Weeks 1–2:</strong> 250 mcg daily</li>
<li><strong>Weeks 3–4:</strong> 500 mcg daily</li>
<li><strong>Maintenance:</strong> 250–500 mcg every 2–3 days</li>
</ul>
<p>Selank may be included in a <a href="https://www.dragonpharma.net/cycles-1933">custom wellness cycle</a> or paired with regenerative peptides like <a href="https://www.dragonpharma.net/peptides-414/bpc-157-48731">BPC 157</a> to support both mental and physical recovery.</p>
<h3>Does Selank Require PCT?</h3>
<p>No. Selank does not suppress hormonal function or alter endocrine pathways, so <a href="https://www.dragonpharma.net/post-cycle-therapy-3855">post-cycle therapy</a> is not needed. It may be discontinued gradually if used for extended periods.</p>
</section>
</div>
Technical Details
Peptide Type
Synthetic Linear Heptapeptide
Peptide Sequence
Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP)
Peptide Length
7 Amino-Acid Residues
Terminal Form
H-TKPRPGP-OH
Structural Origin
Tuftsin-Derived Peptide
Molecular Formula
C₃₃H₅₇N₁₁O₉
Molecular Weight
751.9 g/mol
